BACKGROUND: Venous thromboembolism (VTE) is a multicausal disorder involving environmental and genetic risk factors. In many thrombophilic families the clustering of thrombotic events cannot be explained by known genetic risk factors, indicating that some remain to be discovered. OBJECTIVES: We aimed to identify novel thrombosis susceptibility alleles in a large panel of small thrombophilic families: the Genetics In Familial Thrombosis (GIFT) study. PATIENTS/ METHODS: In the GIFT study, 201 families were recruited consisting of 438 siblings with an objectively confirmed VTE at a young age. Multipoint linkage analysis (402 SSR markers) and fine mapping were performed, followed by genotyping of tagging SNPs in positional candidate genes. RESULTS: Established genetic risk factors such as factor V Leiden, ABO blood group non-O, prothrombin 20210A, fibrinogen gamma 10034T and deficiencies of antithrombin, protein C and protein S were more frequent in GIFT patients than in unselected VTE patients. Linkage supported the presence of novel thrombosis susceptibility loci on 7p21.3-22.2 (LOD score = 3.23) and Xq24-27.3 (LOD score = 1.95). Simulation analysis showed that the chr7 signal was genome-wide statistically significant (P = 0.022). Tagging SNPs (n = 157) in eight positional candidate genes (LOD drop 1.5 regions) were genotyped in GIFT patients and 332 healthy controls. Five chr7 SNPs associated with VTE. SNP THSD7A rs2074597 was responsible for part of the chr7 signal. CONCLUSIONS: The GIFT panel is rich in established genetic risk factors for VTE, but genetic factors remain unidentified in many families. Genome-wide linkage failed to identify the previously established genetic risk factors for VTE, but identified a novel VTE susceptibility locus on chr7.
BACKGROUND:Venous thromboembolism (VTE) is a multicausal disorder involving environmental and genetic risk factors. In many thrombophilic families the clustering of thrombotic events cannot be explained by known genetic risk factors, indicating that some remain to be discovered. OBJECTIVES: We aimed to identify novel thrombosis susceptibility alleles in a large panel of small thrombophilic families: the Genetics In Familial Thrombosis (GIFT) study. PATIENTS/ METHODS: In the GIFT study, 201 families were recruited consisting of 438 siblings with an objectively confirmed VTE at a young age. Multipoint linkage analysis (402 SSR markers) and fine mapping were performed, followed by genotyping of tagging SNPs in positional candidate genes. RESULTS: Established genetic risk factors such as factor V Leiden, ABO blood group non-O, prothrombin 20210A, fibrinogen gamma 10034T and deficiencies of antithrombin, protein C and protein S were more frequent in GIFT patients than in unselected VTEpatients. Linkage supported the presence of novel thrombosis susceptibility loci on 7p21.3-22.2 (LOD score = 3.23) and Xq24-27.3 (LOD score = 1.95). Simulation analysis showed that the chr7 signal was genome-wide statistically significant (P = 0.022). Tagging SNPs (n = 157) in eight positional candidate genes (LOD drop 1.5 regions) were genotyped in GIFT patients and 332 healthy controls. Five chr7 SNPs associated with VTE. SNP THSD7Ars2074597 was responsible for part of the chr7 signal. CONCLUSIONS: The GIFT panel is rich in established genetic risk factors for VTE, but genetic factors remain unidentified in many families. Genome-wide linkage failed to identify the previously established genetic risk factors for VTE, but identified a novel VTE susceptibility locus on chr7.
Authors: Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee Journal: Blood Adv Date: 2017-06-29
Authors: Marine Germain; Daniel I Chasman; Hugoline de Haan; Weihong Tang; Sara Lindström; Lu-Chen Weng; Mariza de Andrade; Marieke C H de Visser; Kerri L Wiggins; Pierre Suchon; Noémie Saut; David M Smadja; Grégoire Le Gal; Astrid van Hylckama Vlieg; Antonio Di Narzo; Ke Hao; Christopher P Nelson; Ares Rocanin-Arjo; Lasse Folkersen; Ramin Monajemi; Lynda M Rose; Jennifer A Brody; Eline Slagboom; Dylan Aïssi; France Gagnon; Jean-Francois Deleuze; Panos Deloukas; Christophe Tzourio; Jean-Francois Dartigues; Claudine Berr; Kent D Taylor; Mete Civelek; Per Eriksson; Bruce M Psaty; Jeanine Houwing-Duitermaat; Alison H Goodall; François Cambien; Peter Kraft; Philippe Amouyel; Nilesh J Samani; Saonli Basu; Paul M Ridker; Frits R Rosendaal; Christopher Kabrhel; Aaron R Folsom; John Heit; Pieter H Reitsma; David-Alexandre Trégouët; Nicholas L Smith; Pierre-Emmanuel Morange Journal: Am J Hum Genet Date: 2015-03-12 Impact factor: 11.025
Authors: Karl C Desch; Ayse B Ozel; Matt Halvorsen; Paula M Jacobi; Krista Golden; Mary Underwood; Marine Germain; David-Alexandre Tregouet; Pieter H Reitsma; Clive Kearon; Lauren Mokry; J Brent Richards; Frances Williams; Jun Z Li; David Goldstein; David Ginsburg Journal: Blood Date: 2020-07-30 Impact factor: 25.476
Authors: Renaud Tissier; Roula Tsonaka; Simon P Mooijaart; Eline Slagboom; Jeanine J Houwing-Duistermaat Journal: Stat Med Date: 2017-03-16 Impact factor: 2.373
Authors: Marisa L R Cunha; Joost C M Meijers; Frits R Rosendaal; Astrid van Hylckama Vlieg; Pieter H Reitsma; Saskia Middeldorp Journal: PLoS One Date: 2017-11-08 Impact factor: 3.240